Fact CheckerSign in

NCT03868384Active, not recruiting

The Effect of Home Blood Pressure Measurement on the Management of Hypertension

Evaluation of Home Blood Pressure Measurement for the Management of Hypertension in Treated Hypertensive Patients

Source: ClinicalTrials.gov · Last updated 12 Jul 2021

Brief summary (registry, in English)

Home blood pressure measurement has been reported to be associated with better clinic blood pressure and daytime blood pressure control. However, no study has evaluated the association between home blood pressure measurement and control of 24-hour ambulatory blood pressure in real world practice. The purpose of the present study is to investigate the effect of home blood pressure measurement on the control of ambulatory blood pressure in the real world. The detailed purposes of the present study are (1) to investigate the effects of home blood pressure measurement on the appropriate control of 24-hour ambulatory blood pressure in hypertensive patients treated with antihypertensive drug, (2) to evaluate the effect of home blood pressure measurement on the occurrence of cardiovascular events and target organ damage, (3) to investigate the status and appropriateness of home blood pressure measurement in the real world, and (4) to investigate factors of home blood pressure measurement methods affecting the treatment of hypertension.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
701 (actual)
First submitted
22 Feb 2019
Start date
1 Aug 2018
Primary completion date
13 May 2020
Lead sponsor
DongGuk University
NCT number
NCT03868384

What you commit to

  • Study type: Observational
  • Participants enrolled: 701
  • From 1 Aug 2018 to the primary completion date, 13 May 2020
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Those who have taken other clinical trial drugs within the past month

Other illness

  • Secondary hypertension
  • Severe heart failure (NYHA III and IV)
  • Angina with 6 months
  • Myocardial infarction within 6 months
  • Peripheral artery disease within 6 months
  • Significant arrhythmia (i.e. ventricular tachycardia and fibrillation, atrial fibrillation, atrial flutter)
  • According to the opinion of the researcher, those who have or may have a disease that may interfere with the completion of the study
  • History of drug or alcohol dependence within 6 months

Other

  • Hypertensive emergency and urgency
  • Pregnancy
  • Night labor, shift worker
  • Those who are currently participating in other clinical studies

Who the study is looking for

  • Patients with hypertension and taking antihypertensive drugs more than 1 year

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dongguk University Ilsan Hospital
Coordinator of this site? Confirm its status
Goyang-siSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.